Skip to main content
David Simon, MD, Neurology, Boston, MA

DavidKSimonMDPhD

Neurology Boston, MA

Movement Disorder, Neurodegenerative

Professor of Neurology at Harvard Medical School; Chief, Division of Neurology - Beth Israel Deaconess Medical Center, and Director, Parkinson's Disease and Movement Disorders Center; Director - National Parkinson Foundation Center of Excellence at Beth Israel Deaconess Medical Center

Dr. Simon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Simon's full profile

Already have an account?

  • Office

    Beth Israel Deaconess Med. Ctr.
    330 Brookline Avenue; Room Cls-638
    Boston, MA 02215
    Phone+1 617-667-0519
    Fax+1 617-735-2826
  • Is this information wrong?

Education & Training

  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1994 - 1997
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1993 - 1994
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1993
  • Washington University in St. Louis
    Washington University in St. LouisPh.D., Neuroscience, 1993
  • Johns Hopkins University
    Johns Hopkins UniversityB.A., Biology, 1986

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1995 - 2024
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • George C. Cotzias Award (for Research) American Parkinson Disease Association (APDA), 2001
  • Irwin Levy Prize in Neurology and Neurological Surgery Washington University School of Medicine, 1993
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial  
    FS-ZONE Investigators (Simon DK), Lancet Neurology, 1/1/2015
  • Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone effects  
    Simon DK, Simuni T, Elm J, Clark-Matott J, Graebner AK, Baker L, Dunlop SR, Emborg M, Kamp C, Morgan JC, Ross GW, Sharma S, Ravina B, on behalf of the NET-PD FS-Zone I..., J Parkinson’s Dis, 1/1/2015
  • No Sex Differences in Use of Dopaminergic Medication in Early Parkinson Disease in the US and Canada - Baseline Findings of a Multicenter Trial  
    Umeh CC, Perez A, Augustine EF, Dhall R, Dewey RB, Mari Z, Simon DK, Wills AA, Christine CW, Schneider JS, Suchowersky O, PLoS ONE, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Multifocal Repetitive Transcranial Magnetic Stimulation Improves Motor and Mood Symptoms of Parkinson’s Disease Equally to a Sham Stimulation: Results of the MASTER-PD...
    Brys M, Biagioni M, Agarwal S, Dacpano G, Kumar P, Pirraglia L, Gray Z, Simon DK, Wu A, Fernandez H, Chen R, Wagle Shukla A, Lou JS, Di Rocco A, Pascual-Leone A, Movement Disorders Society Annual Meeting, San Diego, CA, 1/1/2015
  • A Multi-Center, Double-Blind, Phase II Study of Pioglitazone in Early Parkinson’s Disease.
    NET-PD Investigators (Simon DK), Movement Disorders Society Annual Meeting, San Diego, CA, 1/1/2015
  • Personality and Quality of Life Assessments Before and After Deep Brain Stimulation Surgery in Patients with Parkinson’s Disease.
    Newlon M, O’Connor M, Kapust L, Pierce C, Silver A, Simon DK, Tarsy D, Papavassiliou E, Alterman R, Shih LC, Movement Disorders Society Annual Meeting, San Diego, CA, 1/1/2015
  • Join now to see all

Lectures

  • Clinical Trials and Slowing Progression of Parkinson’s Disease 
    Newton, MA - 1/6/2015
  • Basic Science Breakthroughs. 
    1/1/2015
  • PD101. Parkinson’s Disease Overview. 
    1/1/2015
  • Join now to see all

Other

  • Dystonia. 
    Simon DK, Tarsy D, Shih LC, BMJ Point of Care
    www.pointofcare.bmj.com
    1/1/2014
  • Pioglitazone and neuroprotective therapies for Parkinson’s disease (Interview). 
    Simon D, Healthday
    1/1/2014
  • Mitochondrial Disorders (Interviewed as an expert) 
    Simon D, Yahoo Sports
    1/1/2008
  • Join now to see all

Press Mentions

  • Can a ‘Smart’ Skin Patch Detect Early Neurodegenerative Diseases?
    Can a ‘Smart’ Skin Patch Detect Early Neurodegenerative Diseases?February 1st, 2023
  • Deep Brain Stimulation and New Technology Helping Patient Live Life to the Fullest
    Deep Brain Stimulation and New Technology Helping Patient Live Life to the FullestFebruary 8th, 2022
  • Crackdown on Unproven Stem Cell Therapies Long Overdue, Ottawa Doctor Says
    Crackdown on Unproven Stem Cell Therapies Long Overdue, Ottawa Doctor SaysJuly 10th, 2019
  • Join now to see all

Grant Support

  • Parkinson Disease Neuroprotection Clinical TrialNational Institute Of Neurological Disorders And Stroke2002–2012
  • Mitophagy-Driven Selection Against Heteroplasmic Mitochondrial DNA MutationsNational Institute Of Neurological Disorders And Stroke2011
  • Impact Of Somatic Mitochondrial DNA Point Mutations In The Aging BrainNational Institute On Aging2010–2011
  • Oxidative Stress, Alpha-Synuclein, And Mtdna Mutations In Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2007–2011
  • Somatic Mitochondrial DNA Mutations In Neurons And GliaNational Institute Of Neurological Disorders And Stroke2007
  • Somatic Mitochondiral DNA Mutations In Neurons And GliaNational Institute Of Neurological Disorders And Stroke2006
  • Acquired Mitochondrial DNA Mutations In The BrainNational Institute Of Neurological Disorders And Stroke2002–2006
  • Oxidative Stress And Parkinsons DiseaseNational Institute Of Neurological Disorders And Stroke1998–2001
  • Oxidative Stress And Parkinsons DiseaseNational Institute Of Neurological Disorders And Stroke1997

Professional Memberships